This application represents the completion of a three year process of consolidation of the University of Wisconsin's two National Cancer Institute Funded Cancer Centers. The McArdle Laboratory for Cancer Research Cancer Center Support Grant will complete 37 years of continuous support in April 2001 and The University of Wisconsin Comprehensive Cancer Center will complete 29 years of continuous support in April 2001. The newly consolidated and greatly expanded University of Wisconsin Comprehensive Cancer Center (UWCCC) is a comprehensive, multi-disciplinary, matrix research institute which supports and stimulates study of the basic biology of cancer, the translation of new discoveries to clinical application, and the study of the incidence and public health related issues of controlling what is the National's number one health problem. The ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer. The UWCCC is ultimate goal of the faculty and staff of the UWCCC is the prevention and cure of cancer The UWCCC is composed of 201 faculty members coming from 41 departments and nine different University schools. The faculty is supported in their work by more than 500 staff. The UWCCC is organized into eight collaborative research programs: Cancer Control and Population Sciences; Cancer Genetics; Cell Signaling and Growth Control; Etiology and Chemoprevention; Experimental Therapeutics; Human Cancer Virology; Imaging and Radiation Sciences; and Immunology and immunotherapy. Four of these programs have clinical trial activity and all eight closely interact with fourteen Disease Oriented Multi-disciplinary Working Groups. The present application proposes to continue support for the CCSGs of the two UW Centers as a newly merged and restructured University based comprehensive cancer center. This application requests renewal of comprehensive status and support for senior leaders, program leaders, staff investigators, planning and evaluation, developmental funds, administration, protocol data review and monitoring, support staff for phase I/II clinical trials, and fifteen shared services essential to facilitate and enhance the multi-disciplinary research of the UWCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-32
Application #
6732677
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1976-01-01
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2005-03-31
Support Year
32
Fiscal Year
2004
Total Cost
$5,450,317
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Nayak, Amruta P; Kapur, Arvinder; Barroilhet, Lisa et al. (2018) Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer. Cancers (Basel) 10:
Litzelman, Kristin; Keller, Abiola O; Tevaarwerk, Amye et al. (2018) Adequacy of Depression Treatment in Spouses of Cancer Survivors: Findings From a Nationally Representative US Survey. J Gen Intern Med 33:869-876
Chute, Colleen; Yang, Xinhai; Meyer, Kristy et al. (2018) Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases. Breast Cancer Res 20:66
Farnoodian, Mitra; Sorenson, Christine M; Sheibani, Nader (2018) Negative Regulators of Angiogenesis, Ocular Vascular Homeostasis, and Pathogenesis and Treatment of Exudative AMD. J Ophthalmic Vis Res 13:470-486
Braun, Rudolf K; Chetty, Chandramu; Balasubramaniam, Vivek et al. (2018) Intraperitoneal injection of MSC-derived exosomes prevent experimental bronchopulmonary dysplasia. Biochem Biophys Res Commun 503:2653-2658
Gangnon, Ronald E; Stout, Natasha K; Alagoz, Oguzhan et al. (2018) Contribution of Breast Cancer to Overall Mortality for US Women. Med Decis Making 38:24S-31S
Gurel, Zafer; Sheibani, Nader (2018) O-Linked ?-N-acetylglucosamine (O-GlcNAc) modification: a new pathway to decode pathogenesis of diabetic retinopathy. Clin Sci (Lond) 132:185-198
Li, Chao; Yu, Jiaquan; Paine, Paxton et al. (2018) Double-exclusive liquid repellency (double-ELR): an enabling technology for rare phenotype analysis. Lab Chip 18:2710-2719
Zhan, Yonghua; Ehlerding, Emily B; Shi, Sixiang et al. (2018) Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging. J Biomed Nanotechnol 14:900-909
Schumacher, Jessica R; Neuman, Heather B; Chang, George J et al. (2018) A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25:2587-2595

Showing the most recent 10 out of 1528 publications